Bio Medica Laboratories IPO Subscribed 2.26 Times on Day 3
5paisa Capital Ltd
- 2 min read
Last Updated: 25th May 2026 - 06:24 pm
Bio Medica Laboratories Limited's initial public offering (IPO) closed its three-day subscription window at 2.26 times overall subscription by 5:14 PM on Day 3 (May 25, 2026). The ₹52.43 crore book-build issue, priced at ₹132 to ₹139 per share, received bids for 80,86,000 shares against 35,83,000 shares on offer, with total applications reaching 3,076.
Invest in Indian Markets and Unlock Future Potential With 5paisa!Subscription Status of Bio Medica Laboratories IPO
| Date | QIB (Ex-Anchor) | NII | Individual Investors | Total |
|---|---|---|---|---|
| Day 1 (May 21) | 15.94 | 0.03 | 1.09 | 0.72 |
| Day 2 (May 22) | 15.94 | 0.28 | 1.42 | 1.01 |
| Day 3 (May 25) | 15.94 | 1.30 | 2.92 | 2.26 |
Here are the subscription details for Bio Medica Laboratories IPO Day 3, as of 5:14 PM:
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (₹ Cr.) |
|---|---|---|---|---|
| Market Maker | 1.00 | 1,89,000 | 1,89,000 | 2.63 |
| QIB (Ex-Anchor) | 15.94 | 36,000 | 5,74,000 | 7.98 |
| NII | 1.30 | 17,55,000 | 22,86,000 | 31.78 |
| Individual Investors | 2.92 | 17,92,000 | 52,26,000 | 72.64 |
| Total | 2.26 | 35,83,000 | 80,86,000 | 112.40 |
Key Highlights – Day 3
- Overall subscription reached 2.26 times, improving from Day 2's 1.01 times, driven by a sharp improvement in individual investor and NII demand on the final day.
- Individual investors led at 2.92 times, building steadily from Day 2's 1.42 times, reflecting sustained retail demand for this pharmaceutical contract manufacturing SME IPO.
- Non-institutional investors crossed full subscription at 1.30 times, surging from Day 2's 0.28 times, with sNII at 2.19 times against bNII's subdued 0.86 times.
- Qualified institutional buyers (ex-anchor) maintained a strong 15.94 times throughout all three days, unchanged from Day 1.
- Total applications reached 3,076 on Day 3.
Key Highlights – Day 2
- Overall subscription crossed full subscription at 1.01 times, improving from Day 1's 0.72 times.
- Individual investors improved to 1.42 times from Day 1's 1.09 times.
- Non-institutional investors improved to 0.28 times from Day 1's 0.03 times, with sNII at 0.46 times and bNII at 0.19 times.
- Qualified institutional buyers (ex-anchor) held steady at 15.94 times, unchanged from Day 1.
Key Highlights - Day 1
- Overall subscription reached 0.72 times on Day 1 (May 21, 2026), reflecting moderate initial investor interest in this pharmaceutical contract manufacturing SME IPO.
- Qualified institutional buyers (ex-anchor) showed exceptional opening participation at 15.94 times on Day 1.
- Individual investors crossed full subscription at 1.09 times on Day 1.
- Non-institutional investors showed negligible participation at 0.03 times, with bNII at 0.01 times and sNII at 0.06 times on Day 1.
About Bio Medica Laboratories Limited
Incorporated in August 2015, Bio Medica Laboratories Limited specialises in contract manufacturing of pharmaceutical parenteral formulations including liquid and dry-powder injectables in both single-dose and multi-dose formats for human and veterinary healthcare. The company operates on a B2B model from two GMP and GLP-certified manufacturing facilities in Indore, Madhya Pradesh, and offers a portfolio of 73 products across liquid and dry-powder injectable categories.
- FREE IPO Application
- Apply with Ease
- Pre-Apply for IPOs
- UPI Bid Instantly
Trending on 5paisa
01
5paisa Capital Ltd
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.